Marjan A. Versnel

5.7k total citations
116 papers, 4.4k citations indexed

About

Marjan A. Versnel is a scholar working on Immunology, Physiology and Rheumatology. According to data from OpenAlex, Marjan A. Versnel has authored 116 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Immunology, 36 papers in Physiology and 32 papers in Rheumatology. Recurrent topics in Marjan A. Versnel's work include Salivary Gland Disorders and Functions (30 papers), Systemic Lupus Erythematosus Research (30 papers) and Diabetes and associated disorders (23 papers). Marjan A. Versnel is often cited by papers focused on Salivary Gland Disorders and Functions (30 papers), Systemic Lupus Erythematosus Research (30 papers) and Diabetes and associated disorders (23 papers). Marjan A. Versnel collaborates with scholars based in Netherlands, Sweden and France. Marjan A. Versnel's co-authors include Hemmo A. Drexhage, Cornelia G van Helden-Meeuwsen, Roosmarijn C. Drexhage, Wouter Beumer, J.P. van de Merwe, Zana Brkić, Paul Van Daele, Naomi I. Maria, Virgil A. S. H. Dalm and Manon E. Wildenberg and has published in prestigious journals such as PLoS ONE, Diabetes and European Journal of Biochemistry.

In The Last Decade

Marjan A. Versnel

115 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marjan A. Versnel Netherlands	38	1.3k	1.0k	909	860	689	116	4.4k
Stephen Lake United States	28	964 0.7×	886 0.9×	84 0.1×	1.1k 1.3×	705 1.0×	66	5.6k
Victoria Álvarez Spain	42	768 0.6×	550 0.5×	120 0.1×	1.8k 2.1×	498 0.7×	199	5.4k
Orhun H. Kantarci United States	37	772 0.6×	365 0.4×	174 0.2×	1.1k 1.3×	973 1.4×	133	4.8k
Virgil A. S. H. Dalm Netherlands	31	978 0.7×	629 0.6×	131 0.1×	561 0.7×	408 0.6×	128	2.9k
Jorge I. Alvarez United States	33	1.4k 1.0×	393 0.4×	178 0.2×	1.6k 1.8×	373 0.5×	59	5.5k
Tania Kümpfel Germany	40	1.5k 1.1×	274 0.3×	230 0.3×	1.3k 1.5×	936 1.4×	151	6.3k
Andrew McKeon United States	66	832 0.6×	429 0.4×	111 0.1×	2.1k 2.5×	1.9k 2.8×	260	13.2k
Raymond Hupperts Netherlands	40	1.9k 1.4×	209 0.2×	185 0.2×	635 0.7×	447 0.6×	124	4.9k
Erdem Tüzün Türkiye	32	661 0.5×	177 0.2×	253 0.3×	1.1k 1.3×	418 0.6×	248	6.4k
Sim K. Singhrao United Kingdom	39	906 0.7×	1.5k 1.5×	286 0.3×	1.5k 1.8×	747 1.1×	81	4.9k

Countries citing papers authored by Marjan A. Versnel

Since Specialization

Citations

This map shows the geographic impact of Marjan A. Versnel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjan A. Versnel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjan A. Versnel more than expected).

Fields of papers citing papers by Marjan A. Versnel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marjan A. Versnel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjan A. Versnel. The network helps show where Marjan A. Versnel may publish in the future.

Co-authorship network of co-authors of Marjan A. Versnel

This figure shows the co-authorship network connecting the top 25 collaborators of Marjan A. Versnel. A scholar is included among the top collaborators of Marjan A. Versnel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marjan A. Versnel. Marjan A. Versnel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Björk, Albin, Jasper Rip, Cornelia G van Helden-Meeuwsen, et al.. (2025). Amlexanox inhibits production of type I interferon and suppresses B cell differentiation in vitro: a possible therapeutic option for systemic lupus erythematosus and other systemic inflammatory diseases. RMD Open. 11(2). e005351–e005351.

Bie, Maaike de, Roosmarijn C. Drexhage, Sharon Veenbergen, et al.. (2024). Clinical performance of a novel and rapid bioassay for detection of thyroid-stimulating immunoglobulins in Graves’ orbitopathy patients: a comparison with two commonly used immunoassays. Frontiers in Endocrinology. 15. 1469179–1469179. 2 indexed citations

Gruppen, Mariken, Sander W. Tas, Martine J. Smit, et al.. (2024). Learning from serum markers reflecting endothelial activation: longitudinal data in childhood-onset systemic lupus erythematosus. Lupus Science & Medicine. 11(2). e001190–e001190. 1 indexed citations

Mueller, Yvonne M., Harm de Wit, Cornelia G van Helden-Meeuwsen, et al.. (2023). Targeted multiomics in childhood-onset SLE reveal distinct biological phenotypes associated with disease activity: results from an explorative study. Lupus Science & Medicine. 10(1). e000799–e000799. 6 indexed citations

Burska, Agata, Javier Rodríguez‐Carrio, Robert Biesen, et al.. (2023). Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD Open. 9(1). e002876–e002876. 12 indexed citations

Qi, Hongchao, Cornelia G van Helden-Meeuwsen, Jens Göpfert, et al.. (2022). Serum IFNα2 levels are associated with disease activity and outperform IFN-I gene signature in a longitudinal childhood-onset SLE cohort. Lara D. Veeken. 62(8). 2872–2879. 12 indexed citations

Schonenberg‐Meinema, Dieneke, Cornelia G van Helden-Meeuwsen, Noortje Groot, et al.. (2022). Gene signature fingerprints stratify SLE patients in groups with similar biological disease profiles: a multicentre longitudinal study. Lara D. Veeken. 61(11). 4344–4354. 12 indexed citations

Lendrem, Dennis, James Wason, Jessica Tarn, et al.. (2021). Revisiting the JOQUER trial: stratification of primary Sjögren’s syndrome and the clinical and interferon response to hydroxychloroquine. Rheumatology International. 41(9). 1593–1600. 16 indexed citations

Arteaga-Henríquez, Gara, Bianka Burger, Elif Weidinger, et al.. (2020). Activation and deactivation steps in the tryptophan breakdown pathway in major depressive disorder: A link to the monocyte inflammatory state of patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 107. 110226–110226. 20 indexed citations

10.

Olsson, Peter, Iris L. A. Bodewes, Anna Nilsson, et al.. (2019). Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjögren’s syndrome. Rheumatology International. 39(9). 1575–1584. 9 indexed citations

11.

Bodewes, Iris L. A., Albin Björk, Marjan A. Versnel, & Marie Wahren‐Herlenius. (2018). Innate immunity and interferons in the pathogenesis of Sjögren’s syndrome. Lara D. Veeken. 60(6). 2561–2573. 52 indexed citations

12.

Gibney, Sinead M., Wouter Beumer, Marjan A. Versnel, et al.. (2016). Exaggerated Increases in Microglia Proliferation, Brain Inflammatory Response and Sickness Behaviour upon Lipopolysaccharide Stimulation in Non-Obese Diabetic Mice. NeuroImmunoModulation. 23(3). 137–150. 12 indexed citations

13.

Maria, Naomi I., Petra Vogelsang, & Marjan A. Versnel. (2015). The clinical relevance of animal models in Sjögren’s syndrome: the interferon signature from mouse to man. Arthritis Research & Therapy. 17(1). 172–172. 25 indexed citations

14.

Drexhage, Roosmarijn C., Roos C. Padmos, Nico van Beveren, et al.. (2010). Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients. The International Journal of Neuropsychopharmacology. 13(10). 1369–1381. 134 indexed citations

15.

Wildenberg, Manon E., Cornelia G van Helden-Meeuwsen, Hemmo A. Drexhage, & Marjan A. Versnel. (2008). Altered fractalkine cleavage potentially promotes local inflammation in NOD salivary gland. Arthritis Research & Therapy. 10(3). R69–R69. 13 indexed citations

16.

Cha, Seunghee, Marjan A. Versnel, Françoise Homo‐Delarche, et al.. (2001). Abnormal Organogenesis in Salivary Gland Development May Initiate Adult Onset of Autoimmune Exocrinopathy. PubMed. 18(3). 143–160. 44 indexed citations

17.

Velden, Vincent H. J. van der, H.F.J. Savelkoul, & Marjan A. Versnel. (1998). Bronchial epithelium: morphology, function and pathophysiology in asthma.. EUR Research Repository (Erasmus University Rotterdam). 9(4). 585–97. 38 indexed citations

18.

Delahaye, Mick, et al.. (1996). EXPRESSION OF PLATELET-DERIVED GROWTH FACTOR (PDGF) AND PDGF RECEPTORS IN HUMAN MALIGNANT MESOTHELIOMAIN VITRO ANDIN VIVO. The Journal of Pathology. 178(2). 151–160. 73 indexed citations

19.

Prins, Jan‐Bas, et al.. (1996). Identification of regulatory sequences in the promoter of the PDGF B-chain gene in malignant mesothelioma cell lines. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1317(3). 223–232. 4 indexed citations

20.

Gelder, Teun van, et al.. (1989). Malignant Peritoneal Mesothelioma: A Series of 19 Cases. Digestion. 43(4). 222–227. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact